Contributors
Buy Issue for $25 at JHUP- Contributors
Robert Sparrow, PhD, is an Australian Research Council Future Fellow in the Philosophy Department, a Chief Investigator in the ARC Centre of Excellence for Electromaterials Science, and an Adjunct Associate Professor in the Centre for Human Bioethics at Monash University, where he researches ethical issues raised by new technologies. He has published widely on “human enhancement,” pre-implantation genetic diagnosis, cell technologies, and the ethics of robotics.
G. Owen Schaefer, DPhil, is a Research Fellow at the Centre for Biomedical Ethics, National University of Singapore. He received his DPhil in philosophy from Oxford University (Lincoln College), with a thesis on moral enhancement. Prior to that, he worked for two years as a post-baccalaureate fellow at the National Institutes of Health Clinical Center’s Department of Bioethics. His research interests cover a wide array of issues in applied ethics, and he has previously written on the obligation to participate in research, the nature of the right to withdraw, embryonic stem cell research, human enhancement and in vitro meat.
Rebecca Johnson is a PhD student in Sociology and Social Policy at Princeton, focusing on medical sociology, the sociology of law, and quantitative methods. Prior to that, she spent two years as a pre-doctoral fellow at the NIH Department of Bioethics and graduated with a BA with honors in psychology from Stanford. Her current research, which is supported by a National Science Foundation Graduate Research Fellowship, includes the impact of disease advocacy groups on U.S. policy and demographic patterns in which parents pursue litigation against institutions that serve their children.
David Wendler, PhD, is a senior investigator and Head of the Section on Research Ethics in the Department of Bioethics at the NIH Clinical Center. He is a philosopher trained in the philosophy of science, and metaphysics and epistemology. Dr. Wendler is an attending on the Bioethics Consultation Service and has served as a consultant to numerous organizations, including the Institute of Medicine, the World Health Organization, and the World Medical Association. His current research focuses on clinical trials and clinical care with individuals who are unable to give informed consent. [End Page vi]
